Comparative Pharmacology
Head-to-head clinical analysis: POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5 AND LACTATED RINGER S IN PLASTIC CONTAINER versus POTASSIUM PHOSPHATES.
Peer-Reviewed Evidence
Head-to-head clinical analysis: POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5 AND LACTATED RINGER S IN PLASTIC CONTAINER versus POTASSIUM PHOSPHATES.
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER vs POTASSIUM PHOSPHATES
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Potassium is the major intracellular cation; it is essential for maintenance of intracellular tonicity, transmission of nerve impulses, contraction of cardiac, skeletal, and smooth muscle, and maintenance of normal renal function. Dextrose is a monosaccharide that provides caloric support. Lactated Ringer's solution contains sodium, chloride, potassium, calcium, and lactate in a balanced electrolyte solution; lactate is metabolized to bicarbonate in the liver, providing an alkalinizing effect.
Phosphate ion is essential for energy metabolism, buffer systems, and bone mineralization. Potassium is a critical intracellular cation for nerve conduction, muscle contraction, and acid-base balance. Coadministration restores electrolyte balance and provides phosphate for cellular function.
Potassium chloride 20 mEq in dextrose 5% and lactated Ringer's solution, intravenous infusion over at least 1 hour, typically given as 20 mEq per dose, administered no faster than 10 mEq/h. Frequency depends on serum potassium levels, typically every 4-6 hours.
20-40 mEq elemental phosphorus intravenously over 4-6 hours, typically in adults; dose expressed in mmol phosphate: 10-15 mmol phosphate IV over 4 hours. Oral: 1-2 g (250-500 mg elemental phosphorus) 4 times daily.
None Documented
None Documented
Not applicable (endogenous ion with tight homeostatic regulation; administered potassium is rapidly distributed and eliminated, half-life of distribution ~1-2 hours, but terminal elimination depends on renal function and body stores)
Not applicable as a drug; endogenous phosphate has a terminal elimination half-life of 6-8 hours in the setting of renal impairment, but is not clinically significant in normal physiology.
Primarily renal (>90% excreted unchanged by kidneys); minimal fecal/biliary elimination (<5%)
Renal: approximately 90% as phosphate (reabsorbed variably depending on dietary intake and parathyroid hormone activity). Fecal: <10%.
Category C
Category C
Electrolyte Replenisher
Electrolyte Replenisher